Stocks To Buy Now Blog

All posts by Christopher

Flora Growth Corp. (NASDAQ: FLGC) Expands its Line of Lifestyle Brands Following Vessel’s Merger into a Wholly-Owned Subsidiary

  • Flora Growth has followed through with its definitive agreement to acquire 100% of Vessel’s equity interests
  • This acquisition opens Flora up to the North American market, in addition to expanding its brand portfolio, with a proven operator that has achieved trailing 12-months revenue of $6.6 million and year-over-year growth of 90%
  • It also serves to strengthen Flora’s management with the addition of Vessel’s leadership onto the team
  • This latest acquisition lines up with Flora’s mission to build a connected, design-led collective of plant-based wellness and lifestyle brands that offer customers an unrivaled experience
Flora Growth (NASDAQ: FLGC) has, since its inception, made it its mission to build a connected, design-led collective of plant-based wellness and lifestyle brands that provide customers with a one-of-a-kind experience (https://ibn.fm/HtSvW). In a move to live up to its mission, earlier in November 2021, the company entered into a definitive agreement to acquire Vessel Brand Inc., an industry leader in cannabis consumer technology (https://ibn.fm/eJ3hb). On November 15, 2021, Flora announced having closed the acquisition of Vessel. This marks the addition of an exceptional brand builder with a proven track record of not only launching successful cannabis-related brands but also capturing market share in the rapidly-expanding United States (“U.S.”) cannabis landscape (https://ibn.fm/jScFl). When making the announcement, Luis Merchan, the President and Chief Executive Officer (“CEO”) of Flora Growth, noted, “With this acquisition now closed, we can focus on the execution of our combined expansion strategy.” “The integration of our two organizations is well underway, and the Vessel team is expected to substantially enhance the branding and marketing function of Flora Growth as we look to further increase market share in the global cannabis and wellness markets,” he added. The transaction was pursuant to the terms of the definitive agreement that dates back to early November 2021. As a result, flora Growth now owns 100% of Vessel’s equity interests for a consideration of $8 million in cash and 4,557,318 privately issued Flora common shares. Flora is also optimistic about adding Vessel’s leadership to Flora’s overall management, given their experience in cannabis, sales, marketing, design, and production. The key persons, who include Founder and CEO James Choe, Chief Financial Officer (“CFO”), Garrett Potter, Vice President (“VP”) of Marketing, Jessie Casner, and VP of Performance, Jason Choe, have been responsible for Vessel’s go-to-market strategy. This strategy has allowed the company to achieve a trailing 12-month revenue of $6.6 million and year-over-year growth of 90%. In addition, they are the masterminds behind the company’s direct-to-consumer sales strategy both within the U.S. and Canadian markets. “We are looking forward to formally joining the Flora team and supporting their vision of becoming a global leader in plant-based health and wellness,” noted James Choe. The Vessel team has been keen to commend Flora Growth’s unrivaled cost structure and its rapidly expanding brand portfolio. They are confident that with the strong foundation that Flora has built so far, the company is poised for growth and well-positioned to capitalize on the rapidly expanding cannabis market. For more information, visit the company’s website at www.FloraGrowth.ca. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Facilitates Lighting Network Growth Through Easy-to-Use Platform, Bitcoin Deployment

  • The Lightning Network has seen substantial growth during 2021, some of which is attributed to El Salvador’s adoption of BTC as legal tender
  • LQwD launched its lqwd.tech platform November 17, while simultaneously deploying Bitcoin to ensure platform liquidity
  • Companies leveraging LQwD’s Lightning Network nodes will be able to monitor, deploy, and manage these nodes with no-to-low levels of technical expertise
One of the biggest problems described by users of the bitcoin blockchain is the slow transaction speed, right along with the fees associated with the transaction itself. The innovative Lightning Network was designed as a solution to these issues. The network is a layer 2 payment protocol that uses micropayment channels that promise faster transaction times and lower associated costs. The use of the Lighting Network helps decongest the blockchain and facilitate Bitcoin transactions. This concept was originally proposed in 2015 by Joseph Poon and Thaddeus Dryja and has been in development since. In 2021, the Lightning Network hit several all-time highs, denoting the network’s growing popularity and supporting its expansion. Some of the network’s growth can be attributed to El Salvador’s adoption of Bitcoin as legal tender. At an overall total of 3,255, there is now a record number of bitcoins (“BTC”) in the network. In just one month, approximately 834 BTC has been added to the Lightning Network, and the number is expected to grow even more in the upcoming months (https://ibn.fm/GyDzM). Dedicated to enabling easier access to the Lightning Network, and driving bitcoin adoption through an enterprise-grade infrastructure, financial technology company LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) recently launched a Lightning Network platform-as-a-service (“PaaS”) offering that allows users to send and receive payments instantly, securely, and inexpensively worldwide. LQwD’s opportunity promises:
  • Bitcoin Exposure: LQwD is already securing a substantial position regarding Bitcoin. With increased global adoption, fixed supply, built-in deflation properties, and expanded utility in payments through the Lightning Network, the value of the virtual currency is expected to grow into the next decade.
  • Lightning Network: The use of the Lightning Network is being facilitated by LQwD’s PaaS, which supports the growth and usage of the network by establishing payment channels across the network’s ecosystem.
  • Rapid Growth Industry: Globally, virtual money is becoming revolutionary. The reinvention of currency and the finance industry is happening right before our very eyes while giving users control of their money. Users can use the LQwD platform to send, receive, earn, and conduct transactions 24 hours daily with low associated costs.
LQwD’s platform, lqwd.tech, was launched on November 17. Simultaneously, the company deployed a portion of its own Bitcoin holdings to procure additional nodes and provide liquidity for the newly released platform. Companies leveraging LQwD’s Lightning Network nodes will be able to monitor, deploy, and manage these nodes with no-to-low levels of technical expertise. LQwD believes that the Lightning Network will be a force of global change and the premier monetary exchange network of the future. “The Lightning Network is an extremely dynamic new global monetary network that’s growing exponentially, and we’re excited and fortunate to be a solutions provider in the space,” Albert Szmigielski, Chief Technology Officer for LQwD, stated (https://ibn.fm/kw2ci). “Developing countries such as El Salvador are using and seeing significant adoption, and one of the world’s largest social media platforms – Twitter – is making global tipping on the Lightning Network mainstream with its tipping feature called Tips. Needless to say, we’re looking forward to becoming a major contributor to (and supporter of) Bitcoin’s scaling layer – the Lightning Network.” For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

Cannabis Strategic Ventures Inc. (NUGS) Launches LA-Based Cannabis Dispensary in Number-One Market

  • MDRN (Modern) Tree is key piece of company’s vision to build a full farm-to-sale vertical model
  • NUGS plans to grow MDRN Tree brand, develop model that gives cultivation business wider distribution at potentially higher margins
  • The MDRN Tree location is opening in top cannabis market in the world
Cannabis Strategic Ventures (OTC: NUGS) has announced the grand opening of its first Los-Angeles-based, customer-facing MDRN (Modern) Tree cannabis dispensary (https://ibn.fm/FmGGY). The company started recording sales from the dispensary this month. Last month, NUGS took full operational control of the downtown Los Angeles MDRN Tree cannabis product dispensary, the company’s first in-house, end-market, consumer-facing retail sales outlet. “We continue to build a full farm-to-sale vertical model, and MDRN Tree is a big part of that vision,” said NUGS CEO Simon Yu. “It’s exciting to watch the pieces come together, and we look forward to supplying and growing the MDRN Tree brand, and continuing to develop a model that will give our cultivation business wider distribution at potentially higher margins.” The MDRN Tree location is opening in the top cannabis market in the world. California’s Attorney General Rob Bonta marked the state’s 25th anniversary of the first-in-the-nation medical marijuana program, noting that the market has emerged as “number one in the world” (https://ibn.fm/Tr4S1). Bonta spoke at a recent California NORML conference. “Each day we continue to make history,” he continued in his message. “California is the world’s fifth-largest economy. We are number one in the nation for many things, like starting new businesses. We are number one in manufacturing, agriculture, entertainment, tourism, technology and college graduates. And we are also number one in the world for legal cannabis. Our state has the largest legal cannabis market in the world. “Whether it’s medicinal or recreational adult use, a legal and regulated marketplace ensures the industry is successful,” he continued. “And it ensures product is safe and tested, and specifically when it comes to medicinal use. Our progressive policies recognize that this product is not only popular, it is vital for so many patients.” Cannabis Strategic Ventures also has a wholly owned subsidiary — NUGS Farm North — that is a fully state legal licensed Cannabis cultivator in the state of California. The property has more than six acres of greenhouse. Cannabis Strategic Ventures cultivates and sells cannabis biomass and related cannabis products to the legal cannabis market. For more information, visit the company’s website at www.CannabisStrategic.com. NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

As Markets Keep Wary Eye on Inflation, StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Builds Important Gold Mining Resources

  • The global COVID pandemic has had a significant impact on the world’s markets, but a basic optimism has generally persisted after the shock of the initial outbreak
  • Gold continues to generate interest among investors amid concerns about inflation and the potential for consumer prices to continue in an uncontrolled climb
  • Mineral property acquisition and exploration company StraightUp Resources is focused on potential gold production targets in Ontario, Canada, and has begun to expand its resource portfolio internationally
  • The company’s international interests include a mine recently acquired in Nevada’s historically productive Beatty region, as well as one of the largest silver mining land packages in Peru that is in the negotiation process
Nearly two years into the global COVID pandemic, world capital markets are mining optimism that seems to have forgotten the precipitous declines in the early spring of 2020. Following the shock of COVID’s first year, and political unrest that accompanied it, most market sectors began to recover their losses, although there has been a notable widening of the distance between the best performers and those at the low end of the scale (https://nnw.fm/RNkLd). (https://ibn.fm/hyBzi). Still, fears of breakaway inflation continue to create a wariness among investors, particularly as U.S. consumer prices continue to rise at their highest rate in 30 years (https://nnw.fm/KV7NR). (https://ibn.fm/VQ65A). Such trends have generally strengthened the gold market, which is seen as a buffer against inflationary activity. In August, gold achieved a record high of $2,067.15 per ounce and two major banks expect it to reach $3,000 in 2022, although some other analysts expect gold to lose some momentum upon a conclusion of the pandemic (https://ibn.fm/rvC9t). A decision on Fed leadership in the United States is considered responsible for gold dropping below the $1,800 level this month (https://ibn.fm/WrouN), but many analysts are calling it a buy opportunity before prices potentially rise again early next year (https://ibn.fm/UE6Kw). Mineral explorer and acquisition company StraightUp Resources (CSE: ST) (OTCQB: STUPF) is placing its bets on a strong gold market for years to come, building a portfolio of potential precious metal resource sites in the well-known gold-rich region of Red Lake’s greenstone belt in Ontario, Canada, as well as in a historically productive mining region in southern Nevada, and in the Lima region of Peru. The Canadian properties include options for the RLX North, RLX South, Belanger Red Lake, Bear Head, and Ferdinand gold properties (https://ibn.fm/uqTW2) near Pure Gold Mining’s flagship site, which became Canada’s newest mine when it declared it had reached commercial production in August and increased its throughput by 35 percent over the previous quarter (https://ibn.fm/QOX1n). Canada is the world’s fifth-largest producer of gold and more than 75 percent of its precious metals have come from Ontario and nearby Quebec. The value of gold production in Canada more than tripled between 2008 and 2020, when it crossed the $7.8 billion mark (https://ibn.fm/PNtzs). The Red Lake district has a history of producing over 30 million ounces of gold, and StraightUp has completed high-resolution heli-borne magnetic surveys (“MAGs”) on the Ferdinand and the RLX properties to advance its interests there, with Orix Geoscience contracted to interpret the final report on the Ferdinand survey. “We … continue to position ourselves among top-quality assets and companies,” StraightUp President and CEO Mark Brezer stated after announcing the company’s expansion into the United States by adding Nevada’s West Cat Mine to its properties in September (https://ibn.fm/qPeU7). “(Nevada is) the second-largest (silver) producer in the United States, after Alaska, and, in 2014, Nevada produced roughly 11 million troy ounces — more than half of which came as a byproduct from gold mining.” Negotiations under way for the Peru property could potentially grant StraightUp access to one of the largest silver mining land packages in the country with over $120 million in capitalized expenditures currently in care and maintenance mode (https://ibn.fm/bv9DQ). For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

Marijuana Company of America Inc. (MCOA) Reports Highest Quarterly Revenue Yet in Q3 2021 on the Back of New Acquisition, Expects Another Record-Breaking Quarter in Q4 2021

  • MCOA’s Q3 2021 revenue increased 731% year on year from $53,195 in Q3 2020 to $442,178 in Q3 2021
  • The company attributed this growth to its recent acquisition of cDistro, one of the fastest-growing distributors in North America
  • cDistro’s acquisition is part of a strategic shift as the company looks to expand into new areas within the cannabis industry
  • MCOA expects another record-breaking quarter in Q4 2021 as it anticipates reporting a full quarter of revenue from VBF Brands Inc., its newly acquired cultivation facility in Salinas, California
Marijuana Company of America (OTC: MCOA), a diversified holding company looking to grow its business and further establish itself in the legalized cannabis THC, hemp, and cannabidiol (“CBD”) industries, recently reported the highest quarterly revenue in its history (https://ibn.fm/eReC0). As part of the financial results for three months ended September 30, 2021 (“Q3 2021”), the company reported $442,178 in revenue, up from $53,195 in revenue reported in Q3 2020. This represented a 731% year-on-year increase. In addition, the company’s gross profits grew by 297%, from $16,025 reported in Q3 2020 to $63,687 in the most recent quarter. “During the third quarter 2021, despite the fact that we have been in the midst of a global pandemic, the company produced the highest revenues in its history,” said MCOA CEO Jesus Quintero. “Our Q3 financial performance was strong and reflects our ability, despite being in a challenging environment, to execute on the strategy by diversifying within the Cannabis industry through strategic acquisitions along with organic growth.” MCOA attributes the growth in revenue and gross profits to its new acquisition of cDistro, a company that distributes CBD brands, smoke and vape shop-related products to wholesalers, c-stores, specialty retailers, and consumers in North America. Completed toward the end of Q2 2021, the acquisition positioned MCOA to take advantage of immediate revenue and provided a massive opportunity for the company to establish a significant market share in the specialty distribution space (https://ibn.fm/qa9VG). Notably, cDistro’s acquisition is part of several investments the company has made to enhance its value proposition as well as drive its expansion into new areas within the cannabis industry. In August this year, MCOA announced a strategic shift in its business strategy as it expands into the legalized cannabis THC industry (https://ibn.fm/cbzbx). This move was reflected by the direct investment interest in Natural Plant Extract (“NPE”), an operator of licensed cannabis manufacturing and distribution business in California; potential acquisitions; and THC-oriented strategic partnerships with Cannabis Global Inc and Eco Innovation Group. Moreover, MCOA also announced its financial results for the nine months ended September 30, 2021. Total revenues grew 127% to $493,988 in 2021 up from $217,972 in 2020. The company attributed this increase to $407,589 of product sales from cDistro. MCOA also recorded $12,581 in equipment lease revenues and $73,818 from the sale of organic, plant-based hempsmart(TM) products, including Smart Drops (CBD Drops), Neuro Smart (Patented Brain Pills), and Smart Cream (Pain Cream). “We are confident that the steps we are taking will enable us to maintain a growing strong position as we drive growth across the entire business and maximize value for our stakeholders over the long term. Our expectation is that we should have another record-breaking quarter in Q4 2021, since we will report a full quarter of revenue from [VBF Brands Inc.] our newly acquired cultivation facility in Salinas, California,” added Quintero. The company started out in 2015 as a research and development (“R&D”) company focused exclusively on CBD. However, according to CEO Jesus Quintero, who presented during the October Benzinga Cannabis Capital Conference (https://ibn.fm/eiWGY), MCOA has undergone “an exciting transition.” The company is currently expanding to become an incubator of cannabis business opportunities as it seeks to grow “more vertically than horizontally.” MCOA is also expanding itself in the international market with a presence in South America through its new subsidiaries, hempsmart Brazil and hempsmart Uruguay. For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com. NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Divisional Update Highlights Consistent Program and Product Progress Across the Board

  • MINDCURE plans to schedule a pre-IND meeting with the FDA for its Desire Project during Q1 2022 with a subsequent Phase 2 trial to begin Q3 2022
  • The company expects that the GLP supply of ibogaine will be available for distribution to research partners in Q2 2022
  • Information on MC-106 and MC-808, an expansion of MINDCURE’s drug pipeline, will be released during Q2 2022
As a member of the Digital Therapeutics Alliance, Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) delivers digital therapeutics (“DTx”) that are evidence-based interventions driven by high-quality software to prevent, manage, and treat medical disorders or diseases. DTx can be used independently or with other medications, devices, or therapies, to optimize outcomes and patient care. MINDCURE is a leader in advanced proprietary technology and research centered around psychedelics and is currently advancing multiple programs and products to this end. The attested progress and plans for the immediate future were detailed in an operational update regarding the strategic initiatives of the company’s operating segments – MINDCURE Research and MINDCURE Technology (https://ibn.fm/pjF4K). MINDCURE Research’s update included updates on both The Desire Project and Ibogaine. The company has completed its draft research protocol for the use of MDMA and psychotherapy to treat female hypoactive desire disorder (The Desire Project) and expects a pre-IND meeting with the FDA in Q1 2022 and a subsequent Phase 2 trial to commence in Q3 2022. Earlier in 2021, MINDCURE announced that it would begin chemical synthesis routes to produce fully synthetic ibogaine. In July 2021, MINDCURE applied for patents on two routes for full chemical synthesis and initiated the production of Good Laboratory Practice (“GLP”), leading to the production of Good Manufacturing Practice (“GMP”) ibogaine. The company expects to have a GLP supply available for its research partners in Q2 2022. In addition to The Desire Project and its ibogaine efforts, MINDCURE is continuing to explore its options to expand its drug pipeline. There are two candidate selection programs currently underway for what is internally known as MC-106 and MC-808. More information will be released in Q2 2022. MINDCURE Technology also released an update on its DTx technology, iSTRYM, and its release as a minimum viable product (“MVP”) into partner clinics across North America. Although North America is the largest market for DTx, the global market was valued at $3.4 billion in 2020 and is expected to grow at a CAGR of 31.4% to reach $13.1 billion by 2026 (https://ibn.fm/y2EVV). The market’s expansion can potentially bring multiple opportunities for growth for the company, given the iSTRYM’s capability to easily scale at a global level as a drug-agnostic digital tool and distribution platform. MINDCURE’s unique and diversified approach works with multiple touchpoints, including technology, research, and drug supply and partnerships. The distribution component of its platform was kicked off recently, via the company’s partnership with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF), a biotech company with clinical operations researching, developing, and delivering psychedelic medicine to treat addiction. Under the agreement, MINDCURE will leverage iSTRYM to distribute Awakn’s ketamine-assisted psychotherapy for Alcohol Use Disorder in the United States and Canada. For more information, visit the company’s website at www.MindCure.com. NOTE TO INVESTORS: The latest news and updates relating to MCURF are available in the company’s newsroom at http://ibn.fm/MCURF

DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Steps into Gaming Space with BearClaw Esports Partnership

  • Global videogame revenue is expected to surge 20% to $179.7 billion in 2020
  • DigiMax is entering booming space through its partnership with BearClaw Esports
  • Agreement with BearClaw Esports brings a frictionless, nondisruptive adoption to a growing generation that desires and monetizes from technological advancement
As a result of the global pandemic, video games have emerged as a larger industry than sports and movies combined, according to MarketWatch (https://ibn.fm/vHJOO). Savvy companies are looking to enter the booming space, and DigiMax Global (CSE: DIGI) (OTC: DBKSF) has done exactly that with its new partnership with BearClaw Esports, introducing the gaming industry to its cryptocurrency expertise (https://ibn.fm/adAO7). Gaming and cryptocurrency may make the perfect marriage. The two sectors have much in common. Both have been perceived as “social outcasts,” with many thinking that gamers spend their days in a dark basement, wasting away their lives while cryptocurrency is often rejected as a valid form of currency. In fact, both industries are seeing growing legitimacy. “Videogames have grown to resemble competition-based, interactive movies, and the COVID-19 pandemic has propelled the industry to make more money than movies and North American sports combined,” reported MarketWatch earlier this year. “Global videogame revenue is expected to surge 20% to $179.7 billion in 2020, according to IDC data, making the videogame industry a bigger moneymaker than the global movie and North American sports industries combined.” In addition, both spaces rely on tech savvy individuals for their growth, with programming and code being key components for success as well as cybersecurity being a top priority. Both sectors have also established reputations for setting social trends, carefully leveraging expertise and know-how to connect and communicate with their deeply engaged users bases. For example, Twitch has 15 million daily users, presenting an incredible opportunity for engagement (https://ibn.fm/WWP9g) while Discord, an online community platform initially created for gamers to communicate with one another, has an estimated 140 million users every month and now has a significantly wider appeal (https://ibn.fm/tj6sv). With this backdrop, DigiMax is combining forces with BearClaw Esports. The new partnership will provide BearClaw’s community of streaming gamers and Esports followers with access to CryptoHawk AI products and information. “Esports gamers are well known for their affiliation with cryptocurrencies, with many gamers also using their computer hardware to mine and trade a wide variety of cryptocurrencies,” stated DigiMax, noting that BearClaw attracts more than 200,000 gamers and viewers per month through a variety of events. The company anticipates that combining the BearClaw gaming community with CryptoHawk AI will give BearClaw users to access to CryptoHawk AI for their personal use in trading various cryptocurrencies and allow them to benefit through the CryptoHawk AI affiliate program by referring new subscribers. In addition, introducing the BearClaw gaming community to the CryptoHawk AI predictions solution adds a considerable diverse expansion to the user-base while aligning the BearClaw community with the growing DigiMax partnership community. “The technological savviness and leadership of the gaming industry and its community have always been in the forefront of innovation and AI,” said DigiMax chief technology officer Thierry Hubert. “This is why this partnership and outreach with BearClaw Esports brings a frictionless and nondisruptive adoption to a growing generation that desires and monetizes from technological advancement.” The partnership with BearClaw is indicative of DigiMax’s mission to empower investors to safely invest in cryptocurrencies by harnessing the power of artificial intelligence. The company is committed to unlocking the potential of disruptive technologies by providing advanced financial, predictive, and cryptocurrency solutions across various verticals. DigiMax reveals actionable predictive insight across the financial and human world. For more information, visit the company’s website at www.DigiMax-Global.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Providing Rapid Testing Solutions and Services as Pharmacists’ Roles Expand

  • The pharmacy practice is undergoing an evolution that will see pharmacies play a more significant role in patient care
  • Expanded pharmacy technology has allowed pharmacists to better document patient care and results, and Avricore is playing a central role in making this possible
  • The company’s HealthTab(TM) platform supports multiple rapid, lab-accurate testing instruments, and acts as a network for exchanging and reporting data/results
  • Point-of-care testing has numerous benefits, including improved outcomes and quality of life for patients, limiting the spread of infectious diseases, faster treatment, shorter recovery times, and relieving overworked personnel in primary care centers
Health diagnostics technology innovator, Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), is committed to moving pharmacy forward. Through its flagship HealthTab(TM) platform, the company turns pharmacies into community diagnostic centers, enabling pharmacists to take on more responsibilities in primary health services. With the community pharmacy practice experiencing an important transformation that will alter how the public thinks of community pharmacists’ role, Avricore is playing a central role in promoting this paradigm shift. “Many factors are coinciding to set up community pharmacy for an exciting evolution that will continue to grow in the coming years,” reads an article from the October issue of the Pharmacy Times’ Pharmacy Careers publication (https://ibn.fm/ImrJS). “The business model of health care is rapidly changing as communities need their pharmacies to meet gaps in care. Meanwhile, pharmacy technology has expanded to allow pharmacists to better document patient care and outcomes.” On the pharmacy technology end of the factor-based spectrum is Avricore’s HealthTab platform. HealthTab supports several rapid, lab-accurate testing devices and acts as a network for data exchange and reporting. The integrated devices offer quick onsite results covering infectious diseases, such as COVID-19, influenza A & B, strep, and RSV, as well as chronic conditions, namely diabetes and heart disease (https://ibn.fm/8Qi0k). HealthTab then shares the data with the patients, doctors, and pharmacists, allowing them to track results to ensure targets are being met. Avricore’s system offers proper planning, setup, and execution of point-of-care testing (“POCT”) in pharmacies with a bevy of accompanying benefits. For example, rapid results from POCT can help limit the spread of infectious diseases and promote shorter recovery times, improved outcomes, a better quality of life, and faster treatment. Additionally, the availability of POCT services for infectious diseases at pharmacies would help relieve the overworked personnel and nurses at urgent care centers and primary care stations, especially with the ongoing COVID-19 pandemic (https://ibn.fm/Yon5M). In understanding the underlying advantages of the POCT infrastructure it has built, Avricore is growing its platform’s reach in Canada. Last month, the company announced it had expanded to Western Canada with the rollout of HealthTab in select Shoppers Drug Mart stores in British Columbia. “The launch in Shoppers Drug Mart pharmacies in Ontario has been very successful, and we are very happy to see the program lay the groundwork for expansion,” commented AVCR CEO Hector Bremner in an October 26 press release (https://nnw.fm/XDDhQ). (https://ibn.fm/5ssUA). “Having a real-time patient observation program reporting seamlessly across 3,000 kilometers is very unique and we are very proud to deliver this innovation.” Avricore’s HealthTab, which dovetails with the emerging industry trends in the pharmacy practice, is also capitalizing on the rapidly growing global POCT market. Global Market Insights expects the market size to reach $51.8 billion by 2027, representing a CAGR of more than 7.4% during the forecast period, which runs from 2021 (https://ibn.fm/HwCN7). For more information, visit the company’s website at www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Emerging as Leader in Growing Uranium Mining Market

  • Growth in the uranium mining market is attributable to increase in nuclear fuel spend, reports the Business Research Company
  • Report also noted key factors in projected growth of space, which should reach $10.18 billion by 2020
  • UUUU is the leading U.S. producer of uranium, the fuel for carbon- and emission-free nuclear energy, in the country
The uranium mining market is projected to reach nearly $10.18 billion next year, according to a Business Research Company report, which noted that the industry should see CAGR of 4.6% during the forecast period (https://ibn.fm/vvT93). Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest producer of uranium in the United States, is committed to playing a significant role in the growing market. “The growth in the uranium ore mining market is due to increase in nuclear fuel spend in countries such as Australia, Kazakhstan and Canada owing to increasing spend in the defense industry,” stated the report, which noted that the uranium mining market consists of sales of uranium ores and concentrates by entities that mine and beneficiate uranium-radium-vanadium ores. “However, the market for uranium ore mining is expected to face certain restraints from several factors such as interest rate increases, workforce issues and safety.” The report also observed that the global uranium mining market is based on type and geography, with types of deposits including volcanic-type uranium deposits, sandstone-type uranium deposits and carbonate-siliceous-pelitic rock type uranium deposits. Geographical categories include North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa with Asia-Pacific uranium mining market accounting for the largest share in the global uranium mining market. “The use of autonomous hauling systems trucks in the mining industry is significantly enhancing production efficiency and reducing turnaround time,” the report stated. “Autonomous haulage systems control and track mining vehicle movements, coordinates and autonomously drives off-highway haul trucks operating in a mine. This system increases efficiency by minimizing delays, reducing operating costs and reducing fuel consumption, thereby minimizing carbon emissions. “With increase in mining projects and development of technology, the scope and potential for the global uranium ore mining market is expected to significantly rise in the forecast period,” the report concluded. With nuclear energy expected to see strong growth in the coming years as nations around the world work to provide affordable, sustainable clean energy, Energy Fuels looks to be in an ideal position. The company is the leading producer of uranium, the fuel for carbon- and emission-free nuclear energy, in the country. UUUU is also a major U.S. producer of vanadium and just began commercial production at its mill in Utah of an intermediate rare earth element product, the most advanced rare earth material being produced in the U.S. today. Energy Fuels has more uranium production capacity, licensed mines and processing facilities, and in-ground uranium resources than any other U.S. uranium producer. It boasts diverse cashflow-generating opportunities, including vanadium production, uranium recycling and rare earth processing. For more information, visit the company’s website at www.EnergyFuels.com. NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

10th Annual Pharmaceutical Regulatory Operations & Submissions Conference

Date: December 1-2, 2021 Venue: Virtual Event Q1 Production’s premier event platform offers a refreshing and unparalleled virtual experience. Thoughtfully designed and customizable networking features foster a sense of collaboration and discussion, allowing attendees to make direct connections. This program offers three half-day modules to maximize retention and engagement.
  • Methods of application and influence of technological advancements
  • AI Integration Automation Possibilities
  • Regulatory operations teams and developing strategic skill sets
  • Bridging the gap between associates at the junior and senior levels
  • Dealing with changes in regulatory requirements and global considerations
  • Keeping up with general industry developments
  • Special considerations regarding emerging markets
Through resource management considerations, you will also look at the construction of submission dossiers and efficiency in optimizing the dossier preparation process, including technology and AI integration. The agenda of the conference includes: 

Time-Saving Strategies to Meet Accelerated Regulatory Submission Timelines

  • Allocating resources and outsourcing decisions
  • Prioritizing speed while retaining quality
  • Best practices for large-scale dossier work
  • Validations
  • Hyperlinking
  • Formatting data
  • Hyperlinking Publishing
  • Using automation to satisfy rising demand
  • Having a positive influence on patients in need

Module 1 of the New eCTD fFr Electronic Submissions To The U.S. FDA

Form 2253 submission for promotional materials 
  • Cross-functional training on regulatory and promotional rules
  • Useful resources for additional learning and outreach
  • Setting up a consistent procedure with the promotions department using FDA advice
  • Forums and websites
The conference aims to establish parameters and educate people regarding: 
  • Vendor selection and validation criteria
  • Training and automation integration for support teams
  • Demonstration of value proposition to offset upfront investment and measuring the gains in productivity due to automation

Hiring Conference

  • A review of attributes regarding hiring of staff that have a high association to success
  • Techniques to expand your search and effectively interview
  • A spotlight on problems related to hiring and training personnel long-term talent acquisition and retention strategy

Who Will Benefit the Most from This Conference?

  • Executives working in pharmaceutical companies who are currently working to implement eCTD 4.0 and newly added promotional submissions requirements
  • Those who want to learn about viable automation solutions for workflow processes
  • Those wanting to develop strategies around global submission timelines
This program will also help you to:
  • Understanding your market and how it affects your submission strategy
  • Take a seat at the early product operations decision-making table
  • Take on compliance as a cross-functional responsibility
  • Regulatory agenda advocacy across the organization
For more information about the event, please visit https://ibn.fm/x8g5z

From Our Blog

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): Anticipating Tomorrow’s Imaging Standards Today

September 26, 2025

In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a […]

Rotate your device 90° to view site.